Please find the power point on Gestational Diabetes Mellitus (GDM) . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Gestational diabetes Mellitus is defined as:
“Glucose intolerance of any severity with onset or first recognition during pregnancy”
This definition is applicable irrespective of whether the condition resolves after delivery or not.
It does not exclude the possibility that diabetes could have antedated pregnancy.
Gestational diabetes Mellitus is defined as:
“Glucose intolerance of any severity with onset or first recognition during pregnancy”
This definition is applicable irrespective of whether the condition resolves after delivery or not.
It does not exclude the possibility that diabetes could have antedated pregnancy.
Inorganic (non metallic) irritant Poisons by Sunil Kumar Dahasunil kumar daha
Please find the power point on Inorganic (non metallic) irritants poisons. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Meningoencephalitis. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Migraine. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Tension Type Headache (TTH). I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Management of Sub arachnoid hemorrhage. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Management of antipsychotic overdose. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Carbonmonoxide poisioning and Its management. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Organophosphate poisoning and its management. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Paracetamol poisoning. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Management of febrile seizures. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Management of alcohol withdrawl seizure . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Choice of Antiepileptic drugs. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Acute management of seizure. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)sunil kumar daha
Please find the power point onLymphoma . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Approach to a patient with fever of unknown origin sunil kumar daha
Please find the power point on Approach to a patient with fever of unknown origin . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Fever in a hospitalized patient and its managementsunil kumar daha
Please find the power point on Fever in a hospitalized patient . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Enteric fever and its management. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Antimicrobial resistance. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Please find the power point on Typhus and its managemen. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. Introduction
“Carbohydrate intolerance of variable severity with onset or
first recognition during the present pregnancy”
• Usually presents in late 2nd or during 3rd trimester.
• >50% GDM ultimately develops to overt diabetes by next
15-20 yrs
4. • Positive family history of diabetes
• Previous birth of an overweight baby of ≥4 kg
• Previous stillbirth with pancreatic islet hyperplasia
• Unexplained perinatal loss
• Polyhydramnios or recurrent vaginal candidiasis in present
pregnancy
• Age over 30 years
• Obesity - Diabesity
• Persistent glycosuria
• Ethnic group (East Asian, Pacific island ancestry)
5. Screening: 50g, 1hr oral glucose challenge test
• 1 hr glucose measured
• Cutoff 140 mg/dL
• Time of day, Last meal do not count.
If sensitive consider 100gm (WHO-75 gm) oral glucose
tolerance test.
Low risk group
Average risk group
High risk group
6. • Oral glucose load= 100gm (WHO- 75 gm)
Time Venous Plasma (mg/dl)
Fasting ≥ 95 but <126 at any
Gestational age
1 hour >180
2 hours >155
3 hours >145
O’Sullivan and Mahan modified by Carpenter and Coustan
7. • Symptoms of diabetes or Random Plasma
Glucose concentration of 200 mg/dl or more
According to American Diabetic Association
Time Venous Plasma (mg/dl)
Fasting ≥126 mg/dl
2 hr postprandial ≥200 mg/dl
HbA1C ≥6.5%
8. • Explains how pregnancy makes complication even worst
compared to nonpregnant state.
• Insulin antagonism increased insulin demand.
• “Accelerated Starvation” : pregnancy-induced switch in
fuels from glucose to lipids.
• Hyperemesis + Sympathomimetics + corticosteroids
Ketoacidosis
• More complicated vasculopathy.
9. • Explains simply the complication of diabetes
(Hyperglycemia and adverse pregnancy
outcome)
1) Maternal
2) Fetal and Neonatal
10. During pregnancy
• Abortion
• Preterm labor (20%)
• Infection (UTI and Vulvo-vaginitis)
• Increased incidence of preeclampsia (25%)
• Polyhydramnios (25-50%)
• Maternal distress
• Ketoacidosis and vascular changes
3
Ps
11. During labour:
• Prolongation of labor due to big baby
• Shoulder dystocia
• Perineal injuries
• Post partum haemorrhage
• Operative interference
During puerpurium:
• Puerperal sepsis
• Lactation failure
13. • Polycythemia
• Hypocalcemia (<7 mg/dl)
• Hypomagnesemia (<7 mg/dl)
• Cardiomyopathy
• Long term effects: childhood obesity, neuropsychological
effects and diabetes
14. CNS & Skeletal CVS Renal GI Others
Neural tube
defects
VSD, ASD Renal agenesis Duodenal atresia Single
umbilical
artery
Anencephaly Coarctation of
Aorta
Hydronephrosis Anorectal atresia
Microcephaly Transposition
of great
vesssels
Double ureter Omphalocele
Caudal
Regression
syndrome
Situs inversus Polycystic kidneys Tracheoesophageal
fistula
Sacral agenesis Fallots
tetralogy
15. Preconceptional counselling
• To achieve tight control of diabetes
• Regular monitoring of HbA1C
• Folic acid supplementation
• Appropriate advice on diet and insulin
Principles in the managements are:
• Careful antenatal supervision & glycemic control
• To find out optimum time and method of delivery
• Arrangement for care of the newborn
16. 1. Exercise
Improves cardiorespiratory fitness
Improves physiological and psychological well being
of the patient
2. Glucose monitoring
Routine check up of blood glucose level
HbA1C at end of 1st trimester and trimonthly
thereafter (<6% is desirable)
17. 3. Diet
Caloric consumption should be
30 Kcal/kg for normal weight
24 Kcal/kg for overweight
12 Kcal/kg for morbidly obese women
The constituents of diet may be:
Carbohydrates:40-50%
Proteins: 20%
Fat: 30-40%
Saturated fat<10%,
18. 3. Diet
↑ Complex carbohydrate (Fiber rich diet)
Restricted cholesterol
Avoid sugar
Avoid hematinic and calcium supplements
4. Obstetric management:
If good glycemic control or no need of insulin,
• Women can wait for spontaneous onset of labor
• But, not to excede expected date of delivery
• Elective delivery by induction or CS if requiring insulin
or with complication
19. If diet modification not consistently maintain the
fasting plsma glucose levels <95 mg/dL or the 2 hour
postprandial plasma glucose <120 mg/dL
pharmacological method is recommended. (ACOG,
2013)
20. Insulin therapy
Does not cross placenta.
Starting dose is typically 0.7-1.0 units/kg/day
Given in divided doses
Combination of intermediate acting (isophane) and short
acting insulin.
Subcutaneous insulin infusion by insulin pump preferred
(more physiological)
Oral hypoglycemic agents:
Glibenclamide and metformin (biguanide) used
Both cross placenta but no teratogenic effects
ACOG acknowledges both drugs for first line use.
21. In uncomplicated cases, patient admitted at 34-36 wks
Early hospitalization facilities:
1. Stabilization of diabetes
2. Minimizes the incidence of preeclampsia,
polyhydramnios, preterm labor.
3. Good monitoring fetal wellbeing.
4. Select appropriate time & method of delivery
22. Induction of labor
Indications
1. Diabetic women on insulin after 38 wks
2. Women with vascular complications (Preeclampsia, IUGR) after 37
wks
23. Induction of labor
Methods:
1. Usual insulin dose prior the day to induction
2. No breakfast & no morning dose given on the day
3. Normal saline infused
4. Induction done by low rupture of membrane
5. Oxytocin drip
6. IV drip of 1 lt of 5% dextrose with 10 units of soluble insulin
7. Infusion rate 100-125 ml/hr (1-1.25 units/hr)
8. Blood glucose level estimated hourly
9. Epidural analgesia ideal for pain relief
10. CS if no labor within 6-8 hours or unsatisfactory progression
24. Cesarean section
Indications:
1. Fetal Macrosomia
2. Diabetes with complications
3. Elderly Primigravidae
4. Multigravidae with bad obstetric history
5. Preeclampsia, Polyhydramnios, Malpresentation
25. Procedure
• Scheduled for early morning
• Breakfast and insulin dose omitted
• Capillary blood glucose checked
• NS infusion started
• Dextrose and insulin dose as in induction method
• Prepregnant dose started after the delivery
• Epidural or spinal anesthesia better than general anesthesia
• oral feeding can be started soon after delivery
Cesarean section
26. Puerperium
Antibiotics prophylactically
Breastfeeding encouraged
In lactating women insulin dose is lower
Care of the baby
Kept in NICU for at least 48 hours
Treat complications effectively if arises
Look for congenital malformations
Check blood glucose within 2 hours (hypoglycemia<35mg/dl)
Should be given Vit K 1 mg IM
Breastfeeding within 1/2 - 1 hr and repeat at 3-4 hourly to
minimize hypoglycemia
27. Postpartum Evaluation
• Women diagnosed with GDM should undergo evaluation with a 75g
–OGTT at 6 to 12 weeks postpartum and other intervals thereafter
(Metzger, 2007)
• Women with a history of gestational diabetes are also at risk for
cardiovascular complications associated with dyslipidemia,
hypertension, and abdominal obesity. So must be concerned and
need proper counselling for best health outcome.
28. Contraception
• Low-dose hormonal contraceptives may be used safely.
• Comorbid obesity, hypertension, or dyslipidemia should direct
the choice for contraception toward a method without
potential cardiovascular consequences.
• So what is the alternative ??